Pub Date : 2024-04-27DOI: 10.1007/s11101-024-09964-6
Bruno M. F. Gonçalves, Noélia Duarte, Cátia Ramalhete, Filipa Barbosa, Ana Margarida Madureira, Maria-José U. Ferreira
Indole alkaloids, predominantly found in plants, are a large group of natural product-derived compounds characterized by a remarkable chemical diversity associated with significant biological properties. Among these, terpenoid indole alkaloids are the largest group of secondary metabolites. Tabernaemontana species (Apocynaceae) are widely distributed in tropical and subtropical regions of the world and used in traditional medicine to treat a variety of illnesses, including tumours. These species biosynthesize large quantities of structurally complex monoterpene indole and bisindole alkaloids. Given the compelling biological properties of indole alkaloids, the phytochemical study of Tabernaemontana species has been widely addressed to identify potential anticancer compounds. Several indole alkaloids have shown antiproliferative effect due to different mechanisms, namely by inducing apoptosis or arresting cell cycle, in diverse cancer cell lines, including multidrug-resistant phenotypes. This review primarily aims to underscore the anticancer activity of indole and bisindole alkaloids isolated from several Tabernaemontana species. Moreover, our recent contributions to the field are also highlighted, focusing on the study of Tabernaemontana elegans. The anticancer evaluation, namely the reversion of P-glycoprotein-mediated multidrug resistance, of two sets of monoterpene indole alkaloid derivatives, obtained by modification of some functional groups of two major monoterpene indole alkaloids, is reviewed, as well as the results obtained for a derivative that targeted homologous recombination DNA repair defects.
吲哚生物碱主要存在于植物中,是一大类天然产物衍生化合物,具有显著的化学多样性和重要的生物特性。其中,萜类吲哚生物碱是次生代谢产物中最大的一类。Tabernaemontana(天胡荽科)物种广泛分布于世界热带和亚热带地区,在传统医学中用于治疗包括肿瘤在内的多种疾病。这些物种可生物合成大量结构复杂的单萜吲哚和双吲哚生物碱。鉴于吲哚生物碱具有令人信服的生物特性,人们广泛对 Tabernaemontana 树种进行植物化学研究,以确定潜在的抗癌化合物。一些吲哚生物碱通过不同的机制,即通过诱导细胞凋亡或阻止细胞周期,在不同的癌细胞系(包括耐多药表型)中显示出抗增殖作用。本综述的主要目的是强调从几种 Tabernaemontana 物种中分离出的吲哚和双吲哚生物碱的抗癌活性。此外,还着重介绍了我们最近在该领域的贡献,重点是对 Tabernaemontana elegans 的研究。综述了通过修饰两种主要单萜吲哚生物碱的一些官能团而获得的两组单萜吲哚生物碱衍生物的抗癌评价,即逆转 P 糖蛋白介导的多药耐药性,以及针对同源重组 DNA 修复缺陷的衍生物所取得的成果。
{"title":"Monoterpene indole alkaloids with anticancer activity from Tabernaemontana species","authors":"Bruno M. F. Gonçalves, Noélia Duarte, Cátia Ramalhete, Filipa Barbosa, Ana Margarida Madureira, Maria-José U. Ferreira","doi":"10.1007/s11101-024-09964-6","DOIUrl":"https://doi.org/10.1007/s11101-024-09964-6","url":null,"abstract":"<p>Indole alkaloids, predominantly found in plants, are a large group of natural product-derived compounds characterized by a remarkable chemical diversity associated with significant biological properties. Among these, terpenoid indole alkaloids are the largest group of secondary metabolites. <i>Tabernaemontana</i> species (Apocynaceae) are widely distributed in tropical and subtropical regions of the world and used in traditional medicine to treat a variety of illnesses, including tumours. These species biosynthesize large quantities of structurally complex monoterpene indole and bisindole alkaloids. Given the compelling biological properties of indole alkaloids, the phytochemical study of <i>Tabernaemontana</i> species has been widely addressed to identify potential anticancer compounds. Several indole alkaloids have shown antiproliferative effect due to different mechanisms, namely by inducing apoptosis or arresting cell cycle, in diverse cancer cell lines, including multidrug-resistant phenotypes. This review primarily aims to underscore the anticancer activity of indole and bisindole alkaloids isolated from several <i>Tabernaemontana</i> species. Moreover, our recent contributions to the field are also highlighted, focusing on the study of <i>Tabernaemontana elegans</i>. The anticancer evaluation, namely the reversion of P-glycoprotein-mediated multidrug resistance, of two sets of monoterpene indole alkaloid derivatives, obtained by modification of some functional groups of two major monoterpene indole alkaloids, is reviewed, as well as the results obtained for a derivative that targeted homologous recombination DNA repair defects.</p>","PeriodicalId":733,"journal":{"name":"Phytochemistry Reviews","volume":"55 1","pages":""},"PeriodicalIF":7.7,"publicationDate":"2024-04-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140802486","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-04-27DOI: 10.1007/s11101-024-09965-5
Anja Klančnik, Ajda Kunčič, Sonja Smole Možina, Franz Bucar
The challenge of antimicrobial resistance requires new solutions, and Rhodiola sp. is a promising candidate due to its rich medicinal history. This review focuses on Rhodiola sp., especially R. rosea, highlighting its phytochemical constituents, such as salidroside, rosavins, and other phenolics, and their antimicrobial potential. We investigate the efficacy of Rhodiola sp. against various pathogenic bacteria, suggesting their value in combating antimicrobial resistance. Additionally, Rhodiola compounds are being investigated both as direct antimicrobials and as resistance modifiers that increase the efficacy of antibiotics. Rhodiola extracts and salidroside modulate gut microbiota, thereby affecting health and physiological and metabolic disorders. This illustrates the comprehensive therapeutic potential of Rhodiola sp. We emphasize the importance of understanding the complex interactions between Rhodiola phytochemicals, their antimicrobial effects, and their effects on gut microbiota as well as the need for in-depth research. Further studies will be crucial for the development of holistic treatment approaches. Finally, Rhodiola sp. is highlighted as an important natural resource in the fight against microbial pathogens and antibiotic resistance. Research on Rhodiola sp. should continue to further unravel pharmacological and health-promoting potential and thus address an important public health challenge.
{"title":"The antibacterial potential and effects of Rhodiola sp. on gut microbiota","authors":"Anja Klančnik, Ajda Kunčič, Sonja Smole Možina, Franz Bucar","doi":"10.1007/s11101-024-09965-5","DOIUrl":"https://doi.org/10.1007/s11101-024-09965-5","url":null,"abstract":"<p>The challenge of antimicrobial resistance requires new solutions, and <i>Rhodiola</i> sp. is a promising candidate due to its rich medicinal history. This review focuses on <i>Rhodiola</i> sp., especially <i>R. rosea</i>, highlighting its phytochemical constituents, such as salidroside, rosavins, and other phenolics, and their antimicrobial potential. We investigate the efficacy of <i>Rhodiola</i> sp. against various pathogenic bacteria, suggesting their value in combating antimicrobial resistance. Additionally, <i>Rhodiola</i> compounds are being investigated both as direct antimicrobials and as resistance modifiers that increase the efficacy of antibiotics. <i>Rhodiola</i> extracts and salidroside modulate gut microbiota, thereby affecting health and physiological and metabolic disorders. This illustrates the comprehensive therapeutic potential of <i>Rhodiola</i> sp. We emphasize the importance of understanding the complex interactions between <i>Rhodiola</i> phytochemicals, their antimicrobial effects, and their effects on gut microbiota as well as the need for in-depth research. Further studies will be crucial for the development of holistic treatment approaches. Finally, <i>Rhodiola</i> sp. is highlighted as an important natural resource in the fight against microbial pathogens and antibiotic resistance. Research on <i>Rhodiola</i> sp. should continue to further unravel pharmacological and health-promoting potential and thus address an important public health challenge.</p>","PeriodicalId":733,"journal":{"name":"Phytochemistry Reviews","volume":"85 1","pages":""},"PeriodicalIF":7.7,"publicationDate":"2024-04-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140802428","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-04-24DOI: 10.1007/s11101-024-09957-5
Iman Abdelhady Elshnoudy, Abdallah M. Elkhouly, Mira Masoud, Hanin A. Rabea, Fotouh R. Mansour
The increase in cases of various cancers, the number of cancer patients, and the serious side effects of current chemical treatments have encouraged researchers to discover novel and more effective drugs from plant sources. In this review, PubMed and Scopus were searched for English-language peer-reviewed articles published since 1994, using the keywords: Medicinal plants, Egypt, and Cancer. The inclusion criteria for this systematic review were English peer-reviewed original research articles. A total of 286 studies were included. Studies have shown that the active compounds in certain plants can have anticancer activities by various mechanisms, such as cell cycle arrest, apoptosis induction, and antioxidant effects. Additionally, it is evident that medicinal plants can act as inhibitors of cancer cells. Plants can also act as immune checkpoint inhibitors, which inhibit proteins such as PD-L1 on tumor cells, PD-1 and CTLA-4 on T cells, and help to regulate immune responses. This review also discusses the efficacy of nanoparticles of these plants against cancer cells. The findings indicate the high potential of investigating the bioactive anticancer components of Egyptian medicinal plants for advancing novel treatments that are more effective in combating cancer. The extracts and active compounds of the medicinal plants detailed in this review could provide the foundation for further clinical trials to be conducted, to develop new anticancer drugs.
{"title":"Medicinal plants cultivated in Egypt with anticancer potential; a systematic review","authors":"Iman Abdelhady Elshnoudy, Abdallah M. Elkhouly, Mira Masoud, Hanin A. Rabea, Fotouh R. Mansour","doi":"10.1007/s11101-024-09957-5","DOIUrl":"10.1007/s11101-024-09957-5","url":null,"abstract":"<div><p>The increase in cases of various cancers, the number of cancer patients, and the serious side effects of current chemical treatments have encouraged researchers to discover novel and more effective drugs from plant sources. In this review, PubMed and Scopus were searched for English-language peer-reviewed articles published since 1994, using the keywords: Medicinal plants, Egypt, and Cancer. The inclusion criteria for this systematic review were English peer-reviewed original research articles. A total of 286 studies were included. Studies have shown that the active compounds in certain plants can have anticancer activities by various mechanisms, such as cell cycle arrest, apoptosis induction, and antioxidant effects. Additionally, it is evident that medicinal plants can act as inhibitors of cancer cells. Plants can also act as immune checkpoint inhibitors, which inhibit proteins such as PD-L1 on tumor cells, PD-1 and CTLA-4 on T cells, and help to regulate immune responses. This review also discusses the efficacy of nanoparticles of these plants against cancer cells. The findings indicate the high potential of investigating the bioactive anticancer components of Egyptian medicinal plants for advancing novel treatments that are more effective in combating cancer. The extracts and active compounds of the medicinal plants detailed in this review could provide the foundation for further clinical trials to be conducted, to develop new anticancer drugs.</p></div>","PeriodicalId":733,"journal":{"name":"Phytochemistry Reviews","volume":"24 1","pages":"527 - 583"},"PeriodicalIF":7.3,"publicationDate":"2024-04-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://link.springer.com/content/pdf/10.1007/s11101-024-09957-5.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140662392","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-04-22DOI: 10.1007/s11101-024-09960-w
Yanchun He, Ying Chen, Huaming Tao, Xuefeng Zhou, Juan Liu, Yonghong Liu, Bin Yang
Cyanobacteria are an important source of structurally diverse natural products with excellent biological activities. Until now, amounts of cyanobacteria-derived secondary metabolites have been isolated and most of them have potential applications in a broad spectrum of fields. This review summarizes the source, chemical structures and bioactivities of 520 new compounds obtained from cyanobacteria, most of which are from genus Microcystis, Nostoc, and Moorea, published between 2012 and 2022. The structures of these compounds include peptides, polyketides, amides, terpenoids, steroids, alkaloids and others, among which peptides account for 61.5% of them. Moreover, many compounds display various bioactivities, including cytotoxicity, enzyme inbibition, antibacterial, antimalarial, antitrypanosomal, anti-inflammatory activity, etc. We also summarized the biosynthesis and total synthesis of some representative secondary metabolites from cyanobacteria. In our opinion, these pharmacologically active metabolites with interesting structural diversity will provide medical and chemical researchers with a plenty variety of promising lead compounds from cyanobacteria.